Tech Company Financing Transactions
Tempo Therapeutics Funding Round
On 9/18/2026, Tempo Therapeutics raised $14.5 million in funding from Galaxy-Sirius Partners, Gideon Strategic Partners and Johnson & Johnson Innovation.
Transaction Overview
Company Name
Announced On
9/18/2026
Transaction Type
Venture Equity
Amount
$14,500,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to expand operations and its R&D efforts.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
3030 Bunker Hill Street 104
San Diego, CA 92109
USA
San Diego, CA 92109
USA
Phone
Website
Email Address
Overview
Tempo Therapeutics, headquartered in San Diego, California, is pioneering a new era in tissue engineering biotechnology, using our proprietary MAP material science technology. Using MAP technology, we are building functional tissue and organs within patients to treat disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Westbrook Weaver
Chief Scientific Officer
Donald Griffin
VP - Finance
Shelly Vandertie
VP - Product Management
Sam Timko
VP - R & D
Stephanie Deshayes
Browse more venture capital transactions:
Prev: 9/18/2026: FIZE Medical venture capital transaction
Next: 9/21/2026: Rainmaker Technology venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC transactions reported here come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs